Silgan Holdings IncSLGN · Q2 2024 | $298M | 0% | 7M | $45.46 | $320M | +7.39% |
63001N10663001N106 · Q2 2024 | $298M | 0% | 11M | -- | -- | -- |
Skyline Champion CorpSKY · Q2 2024 | $295M | 0% | 4.4M | $79.91 | $349M | +17.9% |
153527205153527205 · Q2 2024 | $295M | 0% | 8.9M | -- | -- | -- |
G3075P101G3075P101 · Q2 2024 | $295M | 0% | 965.3k | -- | -- | -- |
Hims & Hers Health, Inc.HIMS · Q2 2024 | $294M | 0% | 14.6M | $31.68 | $462M | +56.9% |
iShares MSCI USA Momentum Factor ETFMTUM · Q2 2024 | $294M | 0% | 1.5M | $313.98 | $473M | +61.1% |
Rithm Capital Corp.RITM · Q2 2024 | $293M | 0% | 26.9M | $8.98 | $241M | -17.7% |
600544100600544100 · Q2 2024 | $293M | 0% | 11.1M | -- | -- | -- |
iShares U.S. Technology ETFIYW · Q2 2024 | $292M | 0% | 1.9M | $236.08 | $458M | +56.9% |
Axonics, Inc.AXNX · Q2 2024 | $292M | 0% | 4.3M | $70.98 | $308M | +5.58% |
MasterBrand, Inc.MBC · Q2 2024 | $291M | 0% | 19.9M | $8.58 | $170M | -41.6% |
Talos Energy Inc.TALO · Q2 2024 | $291M | 0% | 23.9M | $15.26 | $365M | +25.6% |
Seacoast Banking Corp of FloridaSBCF · Q2 2024 | $290M | 0% | 12.3M | $33.05 | $405M | +39.8% |
Catalyst Pharmaceuticals, Inc.CPRX · Q2 2024 | $290M | 0% | 18.7M | $31.49 | $589M | +103.3% |
CleanSpark, Inc.CLSK · Q2 2024 | $288M | 0% | 18.1M | $15.61 | $282M | -2.13% |
Sonos IncSONO · Q2 2024 | $288M | 0% | 19.5M | $14.53 | $284M | -1.56% |
Retail Opportunity Investments CorpROIC · Q2 2024 | $288M | 0% | 23.2M | $17.49 | $405M | +40.7% |
YETI Holdings, Inc.YETI · Q2 2024 | $288M | 0% | 7.5M | $50.11 | $378M | +31.3% |
Hawkins, Inc.HWKN · Q2 2024 | $288M | 0% | 3.2M | $139.03 | $439M | +52.8% |
Amdocs Limited - Ordinary SharesDOX · Q2 2024 | $287M | 0% | 3.6M | $51.02 | $186M | -35.4% |
LeMaitre Vascular, Inc.LMAT · Q2 2024 | $286M | 0% | 3.5M | $95.59 | $332M | +16.2% |
Alamo Group, Inc. (ALG)ALG · Q2 2024 | $286M | 0% | 1.7M | $165.35 | $273M | -4.42% |
The Cheesecake Factory IncorporatedCAKE · Q2 2024 | $285M | 0% | 7.3M | $84.46 | $614M | +115% |
Dana IncorporatedDAN · Q2 2024 | $285M | 0% | 23.5M | $27.58 | $649M | +127.6% |
Amedisys Inc - Common StockAMED · Q2 2024 | $285M | 0% | 3.1M | $100.99 | $313M | +10% |
Bright Horizons Family Solutions Inc.BFAM · Q2 2024 | $285M | 0% | 2.6M | $74.32 | $192M | -32.5% |
46429B26746429B267 · Q2 2024 | $283M | 0% | 12.5M | -- | -- | -- |
The Bancorp, Inc.TBBK · Q2 2024 | $283M | 0% | 7.5M | $67.20 | $503M | +78% |
Standex International CorporationSXI · Q2 2024 | $283M | 0% | 1.8M | $308.58 | $541M | +91.5% |
The GEO Group, Inc.GEO · Q2 2024 | $282M | 0% | 19.7M | $31.91 | $627M | +122.2% |
UFP Technologies, Inc.UFPT · Q2 2024 | $281M | 0% | 1.1M | $245.61 | $262M | -6.92% |
World Kinect CorporationWKC · Q2 2024 | $281M | 0% | 10.9M | $36.27 | $395M | +40.6% |
Stepan CompanySCL · Q2 2024 | $281M | 0% | 3.3M | $57.60 | $193M | -31.4% |
Kadant IncKAI · Q2 2024 | $281M | 0% | 956.7k | $310.07 | $297M | +5.54% |
H World Group LimitedHTHT · Q2 2024 | $281M | 0% | 8.4M | $40.62 | $342M | +21.9% |
Marriott Vacations Worldwide CorporationVAC · Q2 2024 | $280M | 0% | 3.2M | $95.41 | $306M | +9.26% |
Freshpet, Inc. - Common StockFRPT · Q2 2024 | $279M | 0% | 2.2M | $57.01 | $123M | -55.9% |
Banc of California, Inc.BANC · Q2 2024 | $279M | 0% | 21.9M | $21.38 | $467M | +67.3% |
Alcon IncALC · Q2 2024 | $279M | 0% | 3.1M | $67.21 | $211M | -24.6% |
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX · Q2 2024 | $279M | 0% | 6.2M | $83.65 | $521M | +86.8% |
OPENLANE, Inc.OPLN · Q2 2024 | $279M | 0% | 16.8M | $39.32 | $661M | +137% |
Liberty Broadband CorpLBRDK · Q2 2024 | $279M | 0% | 5.1M | $29.71 | $151M | -45.8% |
Helix Energy Solutions Group, Inc.HLX · Q2 2024 | $278M | 0% | 23.3M | $9.91 | $231M | -17% |
Supernus Pharmaceuticals, Inc. - Common StockSUPN · Q2 2024 | $278M | 0% | 10.4M | $47.19 | $490M | +76.4% |
Federated Hermes, Inc.FHI · Q2 2024 | $277M | 0% | 8.4M | $57.51 | $485M | +74.9% |
Allison Transmission Holdings, Inc.ALSN · Q2 2024 | $277M | 0% | 3.7M | $119.64 | $437M | +57.6% |
Enterprise Products Partners LPEPD · Q2 2024 | $277M | 0% | 9.6M | $38.77 | $371M | +33.8% |
Rhythm Pharmaceuticals, Inc.RYTM · Q2 2024 | $277M | 0% | 6.7M | $102.66 | $692M | +150% |
SAMSARA INCIOT · Q2 2024 | $276M | 0% | 8.2M | $38.86 | $318M | +15.3% |